fig1
![MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy](https://image.oaes.cc/0f958f15-a9fe-4504-970f-db41e2c05fbd/3140.fig.1.jpg)
Figure 1. Changes in circulating microRNA-126 (cir-miRNA-126) and epidermal growth factor-like domain 7 (cir-EGFL7) during treatment. Median values are illustrated with horizontal lines marking the respective upper and lower limits of the 95% confidence intervals (CI). P-values refer to differences between the individual time points (baseline, operation, and follow-up) based on the Wilcoxon Signed-Rank Test for differences at the medians